Hypertension in a randomized trial of dolutegravir- versus efavirenz-based antiretroviral therapy in pregnant and postpartum women with HIV

By afschroeder • April 14, 2026

Hoffman R, Brummel S, Pinilla M, Malonga G, Chinula L, Stranix-Chibanda L, Machado ES, Naik S, Rathore MH, Pilotto J, Masheto G, Stringer JSA, Shapiro R, Mitchell CD, McCarthy K, João EC, Cressey TR, Hanley S, Jean-Philippe P, Stotz C, Sax P, Currier JS, Lockman S; IMPAACT 2010/VESTED Study Team. Hypertension in a randomized trial of dolutegravir- versus efavirenz-based antiretroviral therapy in pregnant and postpartum women with HIV. Clin Infect Dis. 2026 Apr 13:ciag245. doi: 10.1093/cid/ciag245. Epub ahead of print. PMID: 41973953.

Tags: Infectious Diseases, Publications

Integrating long-acting injectable cabotegravir for HIV prevention into the Brazilian public health system ImPrEP CAB Brasil: a hybrid type-2 implementation-effectiveness cohort study

Grinsztejn B, Torres TS, Hoagland B, Coutinho C, Silva MST, Leite IC, Cunha M, Derrico M, Jalil EM, Cardoso SW, Trefiglio R, Farias A, Mourão[...]

Diagnostics for Hemorrhagic Fever Viruses: Lassa Fever as an Example

Dhar B, Espinoza N, Farzani T, Baudi I, Nosamiefan D, Garcia CY, Allan-Blitz LT, Samani P, Happi C, Sabeti P. Diagnostics for Hemorrhagic Fever Viruses:[...]

Transferrin Enhances Antifungal Therapy and Improves Survival in Experimental Mucormycosis

Gu Y, Gebremariam T, Ibrahim BA, Harb K, Chan A, Ibrahim AS. Transferrin Enhances Antifungal Therapy and Improves Survival in Experimental Mucormycosis. J Fungi (Basel).[...]